279 related articles for article (PubMed ID: 12428243)
1. Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation.
Kissin EY; Lemaire R; Korn JH; Lafyatis R
Arthritis Rheum; 2002 Nov; 46(11):3000-9. PubMed ID: 12428243
[TBL] [Abstract][Full Text] [Related]
2. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen.
Lemaire R; Farina G; Kissin E; Shipley JM; Bona C; Korn JH; Lafyatis R
Arthritis Rheum; 2004 Mar; 50(3):915-26. PubMed ID: 15022335
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma).
Wallis DD; Tan FK; Kielty CM; Kimball MD; Arnett FC; Milewicz DM
Arthritis Rheum; 2001 Aug; 44(8):1855-64. PubMed ID: 11508439
[TBL] [Abstract][Full Text] [Related]
4. Dermal tissue and cellular expression of fibrillin-1 in diffuse cutaneous systemic sclerosis.
Wipff J; Avouac J; Le Charpentier M; Varret M; Houtteman A; Ruiz B; Vacher-Lavenu MC; Kahan A; Boileau C; Allanore Y
Rheumatology (Oxford); 2010 Apr; 49(4):657-61. PubMed ID: 20081226
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the "scleroderma phenotype".
Zhou X; Tan FK; Milewicz DM; Guo X; Bona CA; Arnett FC
J Immunol; 2005 Oct; 175(7):4555-60. PubMed ID: 16177099
[TBL] [Abstract][Full Text] [Related]
6. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
7. Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation and systemic sclerosis.
Lemaire R; Bayle J; Lafyatis R
Curr Opin Rheumatol; 2006 Nov; 18(6):582-7. PubMed ID: 17053502
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
[TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide.
Villano M; Borghini A; Manetti M; Gabbrielli E; Rossi A; Sestini P; Milia A; Nacci F; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
Arthritis Res Ther; 2013 Aug; 15(4):R90. PubMed ID: 23962393
[TBL] [Abstract][Full Text] [Related]
10. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
Ihn H; Yamane K; Kubo M; Tamaki K
Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
[TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis with multiple nodules: characterization of the extracellular matrix.
Moinzadeh P; Agarwal P; Bloch W; Orteu C; Hunzelmann N; Eckes B; Krieg T
Arch Dermatol Res; 2013 Sep; 305(7):645-52. PubMed ID: 23836353
[TBL] [Abstract][Full Text] [Related]
13. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
15. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
17. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
18. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.
Farina G; Lemaire R; Pancari P; Bayle J; Widom RL; Lafyatis R
Ann Rheum Dis; 2009 Mar; 68(3):435-41. PubMed ID: 18408251
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A
Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta (TGF-beta) modulate tenascin-C and fibrillin-1 in bullous keratopathy stromal cells in vitro.
Kenney MC; Zorapapel N; Atilano S; Chwa M; Ljubimov A; Brown D
Exp Eye Res; 2003 Nov; 77(5):537-46. PubMed ID: 14550395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
